Previous Close

$9.46

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

None

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

After a busy June that saw dozens of SPAC merger votes completed, July is shaping up to be another busy month for the SPAC sector. Several of the June mergers saw strong trading patterns after their merger vote, and the de-spacing process had been completed. SPACs could be coming back in favor, making the July SPAC merger vote dates as potential catalysts for many companies in the month.  Here is a look at the current July SPAC merger vote dates: July 8: Vote on the merger for Sunlight Financial with Spartan Acquisition Corporation II (NYSE: SPRQ). The company provides business to business to consumer services for the residential solar market. The company offers loan underwriting, processing, and funding and has funded over $3.5 billion in solar loans. July 12: Vote on the merger for Enovix with Rodgers Silicon Valley Acquisition Corp (NASDAQ: RSVA). Enovix is a lithium-ion battery company targeting markets including wearables, mobile communications, PCs, and AR/VR. Intel Corp (NASDAQ: INTC) and Qualcomm Inc (NASDAQ: QCOM) are customers of Enovix. Related Link: June SPAC Merger Vote Calendar, A Look At Upcoming Votes And Stocks To Watch July 12: Vote on the merger for WheelsUp with Aspirational Consumer Lifestyle Corp (NYSE: ASPL). The private aviation company clocked $261.7 million in revenue in the first quarter, up 68% year-over-year, and saw active members hit 9,896, up 56% year-over-year. The company has a partnership with Delta Air Lines Inc (NYSE: DAL). July 13: Vote on the merger for Markforged with One (NYSE: AONE). 3D printing company Markforged has a large customer base that includes the US Air Force, US Army, US Navy, NASA, SpaceX, Blue Origin, and many aerospace, defense, and automotive companies. Investors in Markforged include Porsche ...

Related tickers: EMPW, SBG, TWND, INTC, SPRQ, MSFT, ASPL, QCOM, RSVA, DAL, LCY, HD, DCRB, LOW, RAAC, OSK, GHVI, AONE, THCB, ANDA, GXGX, CCIV, NHIC, FGNA, PSAC.

Read Full Article

Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE:XEC) from Neutral to Buy. For the first quarter, Cimarex Energy had an EPS of $1.98, compared to year-ago quarter EPS of $0.58. According to B of A Securities, the prior rating for Marathon Oil Corp (NYSE:MRO) was changed from Underperform to Neutral. In the first quarter, Marathon Oil showed an EPS of $0.21, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $14.16 and a 52-week-low of $3.73. Marathon Oil closed at $12.57 at the end of the last trading period. Scotiabank upgraded the previous rating for Westlake Chemical Corp (NYSE:WLK) from Sector Underperform to Sector Perform. In the first quarter, Westlake Chemical showed an EPS of $1.87, compared to $0.65 from the year-ago quarter. At the moment, the stock has a 52-week-high of $106.47 and a 52-week-low of $50.38. Westlake Chemical closed at $91.31 at the end of the last trading period. For Eastman Chemical Co (NYSE:EMN), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. Eastman Chemical earned $2.13 in the first quarter, compared to $2.03 in the year-ago quarter. The current stock performance of Eastman Chemical shows a 52-week-high of $130.47 and a 52-week-low of $65.86. Moreover, at the end of the last trading period, the closing price was at $114.15. According to B. Riley Securities, the prior rating for MarineMax Inc (NYSE:HZO) was changed from Neutral to Buy. In the second quarter, MarineMax showed an EPS of $1.69, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $70.89 and a 52-week-low of $20.12. MarineMax closed at $45.19 at the end of the last trading period. According to B of A Securities, the prior rating for Liberty Oilfield Services Inc (NYSE:LBRT) was changed from Underperform to Neutral. Liberty Oilfield Services earned $0.17 in the first quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Liberty Oilfield Services shows a 52-week-high of $17.78 and a 52-week-low of $4.91. Moreover, at the end of the last trading period, the closing price was at $14.14. See all analyst ratings upgrades.   Downgrades According to Barrington Research, the prior rating for Sykes Enterprises Inc (NASDAQ:SYKE) was changed from Outperform to Market Perform. In the first quarter, Sykes Enterprises showed an EPS of $0.73, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of $53.93 and a 52-week-low of $24.75. At the end of the last trading period, Sykes Enterprises closed at $53.45. B of A Securities downgraded the previous rating for Range Resources Corp (NYSE:RRC) from Neutral to Underperform. In the first quarter, Range Resources showed an EPS of $0.30, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $16.32 and a 52-week-low of $5.08. At the end of the last trading period, Range Resources closed at $14.14. For CAI International Inc (NYSE:CAI), William Blair downgraded the previous rating of Outperform to Market Perform. In the first quarter, CAI International showed an EPS of $1.85, compared to $0.67 from the year-ago quarter. The stock has a 52-week-high of $56.13 and a 52-week-low of $15.51. At the end of the last trading period, CAI International closed at $56.05. Baird downgraded the previous rating for Sykes Enterprises Inc (NASDAQ:SYKE) from Outperform to Neutral. Sykes Enterprises earned $0.73 in the first quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $53.93 and a 52-week-low of $24.75. At the end of the last trading period, Sykes Enterprises closed at $53.45. For Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), Barclays downgraded the previous rating of Equal-Weight to Underweight. In the first quarter, Arcturus Therapeutics showed an EPS of $2.15, compared to $0.67 from the year-ago quarter. The current stock performance of Arcturus Therapeutics shows a 52-week-high of $129.71 and a 52-week-low of $24.87. Moreover, at the ...Full story available on Benzinga.com

Related tickers: OPK, CLNY, BFLY, ZIP, GSAT, DAWN, SYKE, CHPT, ACN, ARCT, CAI, RAPT, LBRT, DBD, MARA, EMN, RIOT, HZO, ESTC, MRO, PAY, SPRQ, RIO, FLYW, RRC, FIGS, SLS, OMIC, WLK, XEC.

Read Full Article
Trending Tickers

Please sign in to view